A Comparison of Legal and Regulatory Management of Medicines in United Kingdom, United States, Canada, and Australia

Review Article

Abstract

Divergent legal and regulatory architectures govern clinical practice, medicines management, and professional liability across the United Kingdom, the United States, Canada, and Australia. While sharing common-law origins, these jurisdictions have developed distinct statutory mechanisms to regulate the prescribing, dispensing, and administration of therapeutics. The evolution of professional accountability is marked by a paradigm shift in the legal standard of care, transitioning from the clinician-led benchmarks of the legacy common-law era to modern, patient-centric doctrines of informed consent. In the United Kingdom, this is codified through the landmark ruling in Montgomery v Lanarkshire Health Board, mirroring parallel jurisprudential pathways established in Australia via Rogers v Whitaker and Canada via Reibl v Hughes, whereas the United States maintains a dual-track approach based on state-specific battery and negligence doctrines. Simultaneously, the regulatory oversight of clinical governance has adapted, as evidenced by the withdrawal of legacy clinical standards and the adoption of collaborative, principles-based guidelines such as those developed by the Royal Pharmaceutical Society. In the digital era, the proliferation of telehealth, cross-border electronic prescribing, and remote patient monitoring introduces unprecedented legal friction, particularly concerning jurisdictional competence, medical malpractice liability, and stringent data protection mandates under the General Data Protection Regulation, the Health Insurance Portability and Accountability Act, the Personal Information Protection and Electronic Documents Act, and the Privacy Act 1988. This review discusses these legal intersections, offering a rigorous jurisprudential critique of statutory guidelines, standard of care evolutions, and the systemic legal challenges arising from transnational digital healthcare delivery